BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28390192)

  • 21. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells.
    Yoshii T; Inohara H; Takenaka Y; Honjo Y; Akahani S; Nomura T; Raz A; Kubo T
    Int J Oncol; 2001 Apr; 18(4):787-92. PubMed ID: 11251175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.
    Lavra L; Rinaldo C; Ulivieri A; Luciani E; Fidanza P; Giacomelli L; Bellotti C; Ricci A; Trovato M; Soddu S; Bartolazzi A; Sciacchitano S
    PLoS One; 2011; 6(6):e20665. PubMed ID: 21698151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
    Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
    Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1.
    Fanfone D; Despretz N; Stanicki D; Rubio-Magnieto J; Fossépré M; Surin M; Rorive S; Salmon I; Vander Elst L; Laurent S; Muller RN; Saussez S; Burtea C
    Med Oncol; 2017 Oct; 34(11):184. PubMed ID: 28986753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas.
    Sancisi V; Borettini G; Maramotti S; Ragazzi M; Tamagnini I; Nicoli D; Piana S; Ciarrocchi A
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2006-15. PubMed ID: 22821892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-3 expression in papillary microcarcinoma of the thyroid.
    Cvejic D; Savin S; Petrovic I; Paunovic I; Tatic S; Krgovic K; Havelka M
    Histopathology; 2005 Aug; 47(2):209-14. PubMed ID: 16045783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
    Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
    Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription Factor HOXA9 is Linked to the Calcification and Invasion of Papillary Thyroid Carcinoma.
    Jin Y; Kim HK; Lee J; Soh EY; Kim JH; Song I; Chung YS; Choi YJ
    Sci Rep; 2019 May; 9(1):6773. PubMed ID: 31043660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expressions of RASSF1A, Galectin-3 and TPO mRNA in papillary thyroid carcinoma and their clinical significance].
    Xu MR; Chen Y; Zhou SR; Chi MM; Chen SL; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):356-60. PubMed ID: 19799084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and tumors.
    Xu J; Filetti S; Hershman JM
    Thyroid; 2008 May; 18(5):533-9. PubMed ID: 18399756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.
    Manzotti G; Torricelli F; Donati B; Sancisi V; Gugnoni M; Ciarrocchi A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):346. PubMed ID: 31395086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
    Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
    De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
    J Nucl Med; 2019 Jun; 60(6):770-776. PubMed ID: 30361380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
    Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.
    Luo L; Xia L; Zha B; Zuo C; Deng D; Chen M; Hu L; He Y; Dai F; Wu J; Wang C; Wang Y; Zhang Q
    Biomed Pharmacother; 2018 Oct; 106():983-990. PubMed ID: 30119270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer.
    Kayed H; Jiang X; Keleg S; Jesnowski R; Giese T; Berger MR; Esposito I; Löhr M; Friess H; Kleeff J
    Br J Cancer; 2007 Oct; 97(8):1106-15. PubMed ID: 17876328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Galectin-3 in diagnosis of thyroid cancer].
    Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
    Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.